おかえりなさい
アカウント登録
siteでログインする
siteで登録する
受信トレイを確認する
BenchSci
About
BenchSci uses AI to empower scientists to run more successful experiments to accelerate drug discovery.
- Toronto,Ontario,Canada
- 101 - 250
- https://www.benchsci.com/
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- $63M
- Industries
- Artificial Intelligence,Biotechnology,Life Science,Machine Learning,Pharmaceutical
- Founded date
- Jan 1, 2015
- Number Of Employee
- 101 - 250
- Operating Status
- Active
- Legal Name
- BenchSci
BenchSci uses AI to empower scientists to run more successful experiments to accelerate drug discovery.BenchSci's vision is to bring medicine to patients 50% faster by 2025. The company empowers scientists with the world’s most advanced biomedical artificial intelligence to run more successful experiments. Backed by F-Prime, Gradient Ventures (Google’s AI fund), and Inovia Capital, BenchSci's proprietary technology accelerates science at 15 top 20 pharmaceutical companies and over 4,300 leading research centers worldwide. BenchSci is a CIX Top 10 Growth company, certified Great Place to Work, and top-ranked company on Glassdoor.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 24, 2022 | Series C | $63M | 2 |
Inovia Capital
TCV
|
— | Detail |
| Feb 4, 2020 | Debt Financing | $7.50M | — | — | — | Detail |
| Feb 4, 2020 | Series B | $22M | 6 |
F-Prime Capital
|
— | Detail |
| Jun 26, 2019 | Series A | $6.68M | 1 |
|
— | Detail |
| May 2, 2018 | Series A | $10.20M | 7 |
Inovia Capital
|
— | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Inovia Capital
|
Yes | Series C |
|
TCV
|
Yes | Series C |
|
F-Prime Capital
|
Yes | Series B |
Golden Ventures
|
— | Series B |
|
|
— | Series B |
Northleaf Capital Partners
|
— | Series B |
|
|
— | Series B |
500 Startups Canada
|
— | Series A |
Afore Capital
|
— | Series A |
Radical Ventures
|
— | Series A |
Employee Profiles
